Senior Director, Health Economics

A. Brett Hauber

Expertise

Pharmaceutical Policy and Economics
Health Economics

Biography

Brett Hauber has over 10 years experience in health and environmental economics in academic, governmental, and research settings. Prior to joining RTI Health Solutions, Dr. Hauber was a policy analyst for the Office of Information and Regulatory Affairs in the Executive Office of the President and an economist in the Center for Economics Research at RTI. He is currently head of the Health Preference Assessment Group and senior director of health economics at RTI. His primary area of specialization is discrete-choice analysis of revealed- and stated-preference data of consumer demand. In his current role, Dr. Hauber oversees RTI’s efforts in health-state utility assessment using conventional techniques such as time tradeoff and standard gamble. His work also includes studies of patient- and physician-stated preferences for pharmaceuticals and other interventions as well as analysis of risk-benefit tradeoff preferences.

Education

PhD, Economics, University of Delaware.

Selected Publications

Bridges, J.F.P., Onukwugha, E., Johnson, F.R., & Hauber, A.B. (Dec. 15, 2007). Patient preference methods - A patient-centered evaluation paradigm. ISPOR Connections, 13 (6):4-7.

Johnson, F.R., Ozdemir, S., Hauber, B., & Kauf, T.L. (Sept 2007). Women's willingness to accept perceived risks for vasomotor symptom relief. Journal of Womens Health, 16 (7):1028-1040.

Hauber, A.B., Johnson, F.R., & Andrews, E.A. (Dec 2006). Risk-Benefit Analysis Methods for Pharmaceutical Decision-Making - Where Are We Now? ISPOR Connections, 12 (6):3-5.

Johnson, F.R., Hauber, A.B., Osoba, D., Hsu, M.A., Coombs, J., & Copley-Merriman, C. (Mar 2006). Are Chemotherapy Patients' HRQoL Importance Weights Consistent with Linear Scoring Rules? A Stated-choice Approach. Quality of Life Research, 15 (2):285-298.

Osoba, D., Hsu, M.A., Copley-Merriman, C., Coombs, J., Johnson, F.R., Hauber, B., Manjunath, R., & Pyles, A. (March 2006). Stated preferences of patients with cancer for health-related quality-of-life (HRQOL) domains during treatment. Quality of Life Research, 15 (2):273-283.

Hauber, A.B., Johnson, F.R., Sauriol, L., & Lescrauwaet, B. (2005). Risking health to avoid injections: preferences of Canadians with type 2 diabetes.. Diabetes Care, 28 (9):2243-2245.

Havranek, E.P., Simon, T.A., L'italien, G., Smitten, A., Hauber, A.B., Chen, R., & Lapuerta, P. (2004 Aug). The relationship between health perception and utility in heart failure patients in a clinical trial: results from an OVERTURE substudy. Journal of Cardiac Failure, 10 (4):339-343.

Richter, A., Hauber, B., Simpson, K., Mauskopf, J.A., & Yin, D. (2002). A Monte Carlo simulation for modelling outcomes of AIDS treatment regimens. Pharmacoeconomics, 20 (4):215-224.

Hauber, A.B., Gnanasakthy, A., Snyder, E.H., Bala, M.V., Richter, A., & Mauskopf, J.A. (2000 Apr). Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmine. Pharmacoeconomics, 17 (4):351-360.

Hauber, A.B., Gnanasakthy, A., & Mauskopf, J.A. (2000 Apr). Savings in the cost of caring for patients with Alzheimer's disease in Canada: an analysis of treatment with rivastigmine. Clinical Therapeutics, 22 (4):439-451.

View all publications by A. Brett Hauber…